Literature DB >> 6583456

Spinal cord tumors induced by N-ethyl-N-nitrosourea in rats: presence of spinal subpial target cells.

M Naito, Y Naito, A Ito, H Watanabe, K Kawashima.   

Abstract

The correlation between induction of spinal cord tumor by N-ethyl-N-nitrosourea (ENU) (CAS: 759-73-9; 1-ethyl-1-nitrosourea) and postnatal cellular differentiation of the spinal cord was examined in 6 different strains of rats [noninbred Wistar and inbred F344, WF, LE, WF (female) X LE (male), and LE (female) X WF (male)]. By perinatal injection of 40 mg ENU/kg, 258 spinal cord tumors were induced in 175 of 372 ENU-treated rats. The spinal cords of rats at ages ranging from day 1 to day 8 after birth were particularly susceptible to the oncogenic effect of ENU. All spinal cord tumors developed in the white matter without any segmental predilection site. Moreover, most (93%) were found in the subpial region of the spinal cord and were classified as oligodendrogliomas. Morphologic and autoradiographic examinations revealed accumulation of spinal subpial immature glial cells from day 1 to day 8 after birth when the spinal cord had a high susceptibility and most of the cells were destined to differentiate into oligodendrocytes. These data show the existence of target cells in the spinal cords of rats after ENU carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6583456

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  2 in total

1.  Periphery of ethylnitrosourea-induced spinal gliomas in rats with special reference to the vascular structure.

Authors:  H Kroh
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Elevated serum growth hormone accelerates gastric tumorigenesis in F344 rats after treatment with N-methyl-N-nitrosourea in their drinking water.

Authors:  H Watanabe; N Fujimoto; K Kawamoto; Y Ando; K Yamada; T Okamoto; G N Kanin; A Ito
Journal:  Jpn J Cancer Res       Date:  1995-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.